Cardiac ion channels and mechanisms for protection against atrial fibrillation

Reviews of Physiology, Biochemistry and Pharmacology

Volumn 162, Issue , 2012, Pages 1-58

  Grunnet, Morten ^a   Bentzen, Bo Hjorth ^a   Sørensen, Ulrik Svane ^a   Diness, Jonas Goldin ^a,b  

^a NEUROSEARCH A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

2' (4 METHOXYPHENYLACETAMIDOMETHYL) N [2 (3 PYRIDYL)ETHYL] 2 BIPHENYLCARBOXAMIDE; 4 [3 (4 BENZYL 1 PIPERIDINYL)PROPIONYL] 2,3,4,5 TETRAHYDRO 7 METHOXY 1,4 BENZOTHIAZEPINE; AMIODARONE; APAMIN; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; CARDIOVASCULAR AGENT; DISOPYRAMIDE; DPO 1; DRONEDARONE; FLECAINIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; ION CHANNEL; KV CHANNEL INTERACTING PROTEIN; KVI 020; NIP 142; NIP 151; NS 8593; NTC 801; PROPAFENONE; RANOLAZINE; S 9947; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; SODIUM CHANNEL NAV1.5; SOTALOL; TEDISAMIL; UNCLASSIFIED DRUG; UNINDEXED DRUG; WYE 160020; XEN D 0101; XEN D 0103;

ABLATION THERAPY; ANGINA PECTORIS; ARTICLE; CALCIUM TRANSPORT; CARDIOVASCULAR RISK; CARDIOVERSION; CHANNEL GATING; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART AUTOMATICITY; HEART DEPOLARIZATION; HEART FAILURE; HEART MUSCLE POTENTIAL; HEART PROTECTION; HEART RATE; HEART REPOLARIZATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE REMODELING; HUMAN; ISCHEMIC HEART DISEASE; LIVER TOXICITY; LUNG FIBROSIS; NEUROLOGIC DISEASE; NONHUMAN; PHOTOSENSITIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; SINUS RHYTHM; THYROID DISEASE; TRIGGER POINT; UNSPECIFIED SIDE EFFECT;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; CALCIUM; CALCIUM CHANNEL BLOCKERS; ELECTROPHYSIOLOGY; HEART; HUMANS; ION CHANNELS; IONS; MODELS, BIOLOGICAL; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS;

EID: 84862837359     PISSN: 03034240     EISSN: 16175786     Source Type: Book Series    
DOI: 10.1007/112_2011_3     Document Type: Article

References (291)

1. Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, Timothy KW, Keating MT, Goldstein SA (1999) MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 97:175-187
2. Allessie MA, Bonke FI, Schopman FJ (1973) Circus movement in rabbit atrial muscle as a mechanism of trachycardia. Circ Res 33:54-62
3. Allessie MA, Bonke FI, Schopman FJ (1975) The mechanism of supraventricular tachycardia induced by a single premature beat in the isolated left atrium of the rabbit. I. Circus movement as a consequence of unidirectional block of the premature impulse. Recent Adv Stud Cardiac Struct Metab 5:303-308
4. Allessie MA, Bonke FI, Schopman FJ (1976) Circus movement in rabbit atrial muscle as a mechanism of tachycardia. II. The role of nonuniform recovery of excitability in the occurrence of unidirectional block, as studied with multiple microelectrodes. Circ Res 39:168-177
5. Allessie MA, Bonke FI, Schopman FJ (1977) Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle. Circ Res 41:9-18 (Pubitemid 8132078)
6. Allessie M, Ausma J, Schotten U (2002) Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 54:230-246 (Pubitemid 34327903)
7. Amos GJ, Wettwer E, Metzger F, Li Q, Himmel HM, Ravens U (1996) Differences between outward currents of human atrial and subepicardial ventricular myocytes. J Physiol 491(Pt 1): 31-50 (Pubitemid 26059547)
8. Andersson B, Abi-Gerges N, Carlsson L (2010) The combined ion channel blocker AZD1305 attenuates late Na current and IKr-induced action potential prolongation and repolarization instability. Europace 12:1003-1010
9. Angelo K, Jespersen T, Grunnet M, Nielsen MS, Klaerke DA, Olesen SP (2002) KCNE5 induces time-and voltage-dependent modulation of the KCNQ1 current. Biophys J 83:1997-2006
10. Antzelevitch C, Burashnikov A (2009) Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation. J Electrocardiol 42:543-548
11. Antzelevitch C, Belardinelli L, Zygmunt AC, Burashnikov A, Di Diego JM, Fish JM, Cordeiro JM, Thomas G (2004) Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation 110:904-910 (Pubitemid 39136212)
12. Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y, Guerchicoff A, Pfeiffer R, Oliva A, Wollnik B, Gelber P, Bonaros EP Jr, Burashnikov E, Wu Y, Sargent JD, Schickel S, Oberheiden R, Bhatia A, Hsu LF, Haissaguerre M, Schimpf R, Borggrefe M, Wolpert C (2007) Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 115:442-449 (Pubitemid 46184195)
13. Antzelevitch C, Burashnikov A, Sicouri S, Belardinelli L (2011) Electrophysiologic basis for the antiarrhythmic actions of ranolazine. Heart Rhythm 8:1281-1290
14. Armoundas AA, Hobai IA, Tomaselli GF, Winslow RL, O'Rourke B (2003) Role of sodium-calcium exchanger in modulating the action potential of ventricular myocytes from normal and failing hearts. Circ Res 93:46-53 (Pubitemid 36859040)
15. Arya A, Silberbauer J, Teichman SL, Milner P, Sulke N, Camm AJ (2009) A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology. Europace 11:458-464
16. Attwell D, Cohen I, Eisner D, Ohba M, Ojeda C (1979) The steady state TTX-sensitive ("window") sodium current in cardiac Purkinje fibres. Pflugers Arch 379:137-142 (Pubitemid 9220338)
17. Bachmann A, Gutcher I, Kopp K, Brendel J, Bosch RF, Busch AE, Gogelein H (2001) Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes. Naunyn Schmiedebergs Arch Pharmacol 364:472-478 (Pubitemid 33020826)
18. Backx PH, Marban E (1993) Background potassium current active during the plateau of the action potential in guinea pig ventricular myocytes. Circ Res 72:890-900 (Pubitemid 23077779)
19. Barfod ET, Moore AL, Lidofsky SD (2001) Cloning and functional expression of a liver isoform of the small conductance Ca2+-activated K+ channel SK3. Am J Physiol Cell Physiol 280:C836-C842
20. Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G (1996) K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 384:78-80 (Pubitemid 26374591)
21. Bean BP (1985) Two kinds of calcium channels in canine atrial cells. Differences in kinetics, selectivity, and pharmacology. J Gen Physiol 86:1-30 (Pubitemid 15073063)
22. Bechard J, Gibson JK, Killingsworth CR, Wheeler JJ, Schneidkraut MJ, Huang J,Ideker RE, McAfee DA (2011) Vernakalant selectively prolongs atrial refractoriness with no effect on ventricular refractoriness or defibrillation threshold in pigs. J Cardiovasc Pharmacol 57:302-307
23. Bendahhou S, Marionneau C, Haurogne K, Larroque MM, Derand R, Szuts V, Escande D, Demolombe S, Barhanin J (2005) In vitro molecular interactions and distribution of KCNE family with KCNQ1 in the human heart. Cardiovasc Res 67:529-538 (Pubitemid 41019560)
24. Bennett PB, Yazawa K, Makita N, George AL Jr (1995) Molecular mechanism for an inherited cardiac arrhythmia. Nature 376:683-685
25. Berkefeld H, Fakler B, Schulte U (2010) Ca2+-activated K+ channels: from protein complexes to function. Physiol Rev 90:1437-1459
26. Bers DM (2002) Cardiac excitation-contraction coupling. Nature 415:198-205 (Pubitemid 34059525)
27. Bers DM, Perez-Reyes E (1999) Ca channels in cardiac myocytes: structure and function in Ca influx and intracellular Ca release. Cardiovasc Res 42:339-360 (Pubitemid 29243162)
28. Billman GE (2010) Vernakalant, a mixed sodium and potassium ion channel antagonist that blocks K(v)1.5 channels, for the potential treatment of atrial fibrillation. Curr Opin Investig Drugs 11: 1048-1058
29. Blaauw Y, Gogelein H, Tieleman RG, van Hunnik A, Schotten U, Allessie MA (2004) "Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat. Circulation 110:1717-1724 (Pubitemid 39299211)
30. Black IW, Fatkin D, Sagar KB, Khandheria BK, Leung DY, Galloway JM, Feneley MP, Walsh WF, Grimm RA, Stollberger C et al (1994) Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. Circulation 89:2509-2513
31. Blass BE, Fensome A, Trybulski E, Magolda R, Gardell SJ, Liu K, Samuel M, Feingold I, Huselton C, Jackson CM, Djandjighian L, Ho D, Hennan J, Janusz JM (2009) Selective Kv1.5 blockers: development of (R)-1-(methylsulfonylamino)-3- [2-(4-methoxyphenyl) ethyl]-4-(4-methoxypheny l)-2-imidazolidinone (KVI-020/WYE-160020) as a potential treatment for atrial arrhythmia. J Med Chem 52:6531-6534
32. Bond CT, Pessia M, Xia XM, Lagrutta A, Kavanaugh MP, Adelman JP (1994) Cloning and expression of a family of inward rectifier potassium channels. Receptors Channels 2:183-191 (Pubitemid 24325439)
33. Bond CT, Maylie J, Adelman JP (1999) Small-conductance calcium-activated potassium channels. Ann N Y Acad Sci 868:370-378 (Pubitemid 29281137)
34. Bosch RF, Zeng X, Grammer JB, Popovic K, Mewis C, Kuhlkamp V (1999) Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc Res 44:121-131 (Pubitemid 29431690)
35. Bosch RF, Scherer CR, Rub N, Wohrl S, Steinmeyer K, Haase H, Busch AE, Seipel L, Kuhlkamp V (2003) Molecular mechanisms of early electrical remodeling: transcriptional downregulation of ion channel subunits reduces I(Ca, L) and I(to) in rapid atrial pacing in rabbits. J Am Coll Cardiol 41:858-869 (Pubitemid 36308398)
36. Boyett MR, Honjo H, Kodama I (2000) The sinoatrial node, a heterogeneous pacemaker structure. Cardiovasc Res 47:658-687
37. Boyle WA, Nerbonne JM (1992) Two functionally distinct 4-aminopyridine-sensitive outward K+ currents in rat atrial myocytes. J Gen Physiol 100:1041-1067 (Pubitemid 23042229)
38. Brandt MC, Priebe L, Bohle T, Sudkamp M, Beuckelmann DJ (2000) The ultrarapid and the transient outward K(+) current in human atrial fibrillation. Their possible role in postoperative atrial fibrillation. J Mol Cell Cardiol 32:1885-1896
39. Bredt DS, Wang TL, Cohen NA, Guggino WB, Snyder SH (1995) Cloning and expression of two brain-specific inwardly rectifying potassium channels. Proc Natl Acad Sci USA 92: 6753-6757
40. Brown AM, Birnbaumer L (1990) Ionic channels and their regulation by G protein subunits. Annu Rev Physiol 52:197-213 (Pubitemid 20103534)
41. Burashnikov A, Antzelevitch C (2003) Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity. Circulation 107:2355-2360 (Pubitemid 36578508)
42. Burashnikov A, Antzelevitch C (2010) New developments in atrial antiarrhythmic drug therapy. Nat Rev Cardiol 7:139-148
43. Burashnikov A, Di Diego JM, Zygmunt AC, Belardinelli L, Antzelevitch C (2007) Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine. Circulation 116:1449-1457 (Pubitemid 47480635)
44. Burashnikov A, Belardinelli L, Antzelevitch C (2010a) Acute dronedarone is inferior to amiodarone in terminating and preventing atrial fibrillation in canine atria. Heart Rhythm 7: 1273-1279
45. Burashnikov A, Sicouri S, Di Diego JM, Belardinelli L, Antzelevitch C (2010b) Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation. J Am Coll Cardiol 56:1216-1224
46. Burashnikov A, Zygmunt AC, Di Diego JM, Linhardt G, Carlsson L, Antzelevitch C (2010c) AZD1305 exerts atrial predominant electrophysiological actions and is effective in suppressing atrial fibrillation and preventing its reinduction in the dog. J Cardiovasc Pharmacol 56: 80-90
47. Burke MA, Mutharasan RK, Ardehali H (2008) The sulfonylurea receptor, an atypical ATP-binding cassette protein, and its regulation of the KATP channel. Circ Res 102:164-176 (Pubitemid 351651120)
48. Camm AJ, Capucci A, Hohnloser SH, Torp-Pedersen C, Van Gelder IC, Mangal B, Beatch G (2011) A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. J Am Coll Cardiol 57:313-321
49. Carbone E, Lux HD (1987) Kinetics and selectivity of a low-voltage-activated calcium current in chick and rat sensory neurones. J Physiol 386:547-570 (Pubitemid 17059735)
50. Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, Walter S, Tebbe U (2003) Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 41:1690-1696 (Pubitemid 36584236)
51. Carlsson L, Andersson B, Linhardt G, Lofberg L (2009) Assessment of the ion channel-blocking profile of the novel combined ion channel blocker AZD1305 and its proarrhythmic potential versus dofetilide in the methoxamine-sensitized rabbit in vivo. J Cardiovasc Pharmacol 54: 82-89
52. Carmeliet E (1992) Voltage-and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide. J Pharmacol Exp Ther 262:809-817
53. Carvas M, Nascimento BC, Acar M, Nearing BD, Belardinelli L, Verrier RL (2010) Intraper-icardial ranolazine prolongs atrial refractory period and markedly reduces atrial fibrillation inducibility in the intact porcine heart. J Cardiovasc Pharmacol 55:286-291
54. Cha TJ, Ehrlich JR, Chartier D, Qi XY, Xiao L, Nattel S (2006) Kir3-based inward rectifier potassium current: potential role in atrial tachycardia remodeling effects on atrial repolariza-tion and arrhythmias. Circulation 113:1730-1737 (Pubitemid 43958465)
55. Choisy SC, Arberry LA, Hancox JC, James AF (2007) Increased susceptibility to atrial tachyar-rhythmia in spontaneously hypertensive rat hearts. Hypertension 49:498-505
56. Christ T, Boknik P, Wohrl S, Wettwer E, Graf EM, Bosch RF, Knaut M, Schmitz W, Ravens U, Dobrev D (2004) L-type Ca2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 110:2651-2657 (Pubitemid 39453015)
57. Christ T, Wettwer E, Voigt N, Hala O, Radicke S, Matschke K, Varro A, Dobrev D, Ravens U (2008) Pathology-specific effects of the IKur/Ito/IK, ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation. Br J Pharmacol 154:1619-1630
58. Comtois P, Kneller J, Nattel S (2005) Of circles and spirals: bridging the gap between the leading circle and spiral wave concepts of cardiac reentry. Europace 7(Suppl 2):10-20
59. Comtois P, Sakabe M, Vigmond EJ, Munoz M, Texier A, Shiroshita-Takeshita A, Nattel S (2008) Mechanisms of atrial fibrillation termination by rapidly unbinding Na+ channel blockers: insights from mathematical models and experimental correlates. Am J Physiol Heart Circ Physiol 295:H1489-H1504
60. Conrath CE, Opthof T (2006) Ventricular repolarization: an overview of (patho)physiology, sympathetic effects and genetic aspects. Prog Biophys Mol Biol 92:269-307 (Pubitemid 44302010)
61. Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, Josephson RA, Kellen JC, Klein RC, Krahn AD, Mickel M, Mitchell LB, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG (2004) Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 109:1509-1513 (Pubitemid 38420179)
62. Dale TJ, Cryan JE, Chen MX, Trezise DJ (2002) Partial apamin sensitivity of human small conductance Ca2+-activated K+ channels stably expressed in Chinese hamster ovary cells. Naunyn Schmiedebergs Arch Pharmacol 366:470-477
63. Date T, Takahashi A, Iesaka Y, Miyazaki H, Yamane T, Noma K, Nuruiki N, Ishikawa S, Kanae K, Mochizuki S (2002) Effect of low-dose isoproterenol infusion on left atrial appendage function soon after cardioversion of chronic atrial tachyarrhythmias. Int J Cardiol 84:59-67 (Pubitemid 34718091)
64. Davidenko JM, Pertsov AV, Salomonsz R, Baxter W, Jalife J (1992) Stationary and drifting spiral waves of excitation in isolated cardiac muscle. Nature 355:349-351
65. Davy JM, Herold M, Hoglund C, Timmermans A, Alings A, Radzik D, Van Kempen L (2008) Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study. Am Heart J 156(527):e521-e529
66. de Haan S, Greiser M, Harks E, Blaauw Y, van Hunnik A, Verheule S, Allessie M, Schotten U (2006) AVE0118, blocker of the transient outward current (I(to)) and ultrarapid delayed rectifier current (I(Kur)), fully restores atrial contractility after cardioversion of atrial fibrillation in the goat. Circulation 114:1234-1242 (Pubitemid 44402048)
67. DeCara JM, Pollak A, Dubrey S, Falk RH (2000) Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutter. Am J Cardiol 86(685-688):A688
68. DeMaria CD, Soong TW, Alseikhan BA, Alvania RS, Yue DT (2001) Calmodulin bifurcates the local Ca2+ signal that modulates P/Q-type Ca2+ channels. Nature 411:484-489 (Pubitemid 32494395)
69. Demolis JL, Martel C, Funck-Brentano C, Sachse A, Weimann HJ, Jaillon P (1997) Effects of tedisamil, atenolol and their combination on heart and rate-dependent QT interval in healthy volunteers. Br J Clin Pharmacol 44:403-409 (Pubitemid 27402117)
70. Dhar Malhotra J, Chen C, Rivolta I, Abriel H, Malhotra R, Mattei LN, Brosius FC, Kass RS, Isom LL (2001) Characterization of sodium channel alpha-and beta-subunits in rat and mouse cardiac myocytes. Circulation 103:1303-1310 (Pubitemid 32221356)
71. Diness JG, Sorensen US, Nissen JD, Al-Shahib B, Jespersen T, Grunnet M, Hansen RS (2010) Inhibition of small-conductance Ca2 +-activated K + channels terminates and protects against atrial fibrillation. Circ Arrhythm Electrophysiol 3:380-390
72. Diness JG, Skibsbye L, Jespersen T, Bartels ED, Sorensen US, Hansen RS, Grunnet M (2011) Effects on atrial fibrillation in aged hypertensive rats by Ca(2 +)-activated K( +) channel inhibition. Hypertension 57:1129-1135
73. Dobrev D, Ravens U (2003) Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res Cardiol 98:137-148 (Pubitemid 36740668)
74. Dobrev D, Friedrich A, Voigt N, Jost N, Wettwer E, Christ T, Knaut M, Ravens U (2005) The G protein-gated potassium current I(K, ACh) is constitutively active in patients with chronic atrial fibrillation. Circulation 112:3697-3706 (Pubitemid 43739509)
75. Dorian P, Pinter A, Mangat I, Korley V, Cvitkovic SS, Beatch GN (2007) The effect of vernakalant (RSD1235), an investigational antiarrhythmic agent, on atrial electrophysiology in humans. J Cardiovasc Pharmacol 50:35-40 (Pubitemid 47220444)
76. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL et al (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324:781-788
77. Eisner DA, Vaughan-Jones RD (1983) Do calcium-activated potassium channels exist in the heart? Cell Calcium 4:371-386 (Pubitemid 14154084)
78. Ellinor PT, Lunetta KL, Glazer NL, Pfeufer A, Alonso A, Chung MK, Sinner MF, de Bakker PI, Mueller M, Lubitz SA, Fox E, Darbar D, Smith NL, Smith JD, Schnabel RB, Soliman EZ, Rice KM, Van Wagoner DR, Beckmann BM, van Noord C, Wang K, Ehret GB, Rotter JI, Hazen SL, Steinbeck G, Smith AV, Launer LJ, Harris TB, Makino S, Nelis M, Milan DJ, Perz S, Esko T, Kottgen A, Moebus S, Newton-Cheh C, Li M, Mohlenkamp S, Wang TJ, Kao WH, Vasan RS, Nothen MM, MacRae CA, Stricker BH, Hofman A, Uitterlinden AG, Levy D, Boerwinkle E, Metspalu A, Topol EJ, Chakravarti A, Gudnason V, Psaty BM, Roden DM, Meitinger T, Wichmann HE, Witteman JC, Barnard J, Arking DE, Benjamin EJ, Heckbert SR, Kaab S (2010) Common variants in KCNN3 are associated with lone atrial fibrillation. Nat Genet 42:240-244
79. Epstein AE, Bigger JT Jr, Wyse DG, Romhilt DW, Reynolds-Haertle RA, Hallstrom AP (1991) Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in the entire population enrolled. J Am Coll Cardiol 18:14-19
80. Fakler B, Brandle U, Glowatzki E, Weidemann S, Zenner HP, Ruppersberg JP (1995) Strong voltage-dependent inward rectification of inward rectifier K+ channels is caused by intracellu-lar spermine. Cell 80:149-154
81. Fatkin D, Kelly RP, Feneley MP (1994) Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 23:961-969 (Pubitemid 24090884)
82. Fedida D (2007) Vernakalant (RSD1235): a novel, atrial-selective antifibrillatory agent. Expert Opin Investig Drugs 16:519-532 (Pubitemid 46554469)
83. Fedida D, Orth PM, Chen JY, Lin S, Plouvier B, Jung G, Ezrin AM, Beatch GN (2005) The mechanism of atrial antiarrhythmic action of RSD1235. J Cardiovasc Electrophysiol 16: 1227-1238
84. Feng J, Xu D, Wang Z, Nattel S (1998) Ultrarapid delayed rectifier current inactivation in human atrial myocytes: properties and consequences. Am J Physiol 275:H1717-H1725
85. Fermini B, Wang Z, Duan D, Nattel S (1992) Differences in rate dependence of transient outward current in rabbit and human atrium. Am J Physiol 263:H1747-H1754 (Pubitemid 23030727)
86. Findlay I (2004) Physiological modulation of inactivation in L-type Ca2+ channels: one switch. J Physiol 554:275-283 (Pubitemid 38181342)
87. Flagg TP, Kurata HT, Masia R, Caputa G, Magnuson MA, Lefer DJ, Coetzee WA, Nichols CG (2008) Differential structure of atrial and ventricular KATP: atrial KATP channels require SUR1. Circ Res 103:1458-1465
88. Ford JW, Milnes JT (2008) New drugs targeting the cardiac ultra-rapid delayed-rectifier current (I Kur): rationale, pharmacology and evidence for potential therapeutic value. J Cardiovasc Pharmacol 52:105-120
89. Fozzard HA, Hanck DA (1996) Structure and function of voltage-dependent sodium channels: comparison of brain II and cardiac isoforms. Physiol Rev 76:887-926 (Pubitemid 26286081)
90. Freestone B, Lip GY (2004) Tedisamil: a new novel antiarrhythmic. Expert Opin Investig Drugs 13:151-160 (Pubitemid 38240030)
91. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS (2011) 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 57:e101-e198
92. Fye WB (2006) Tracing atrial fibrillation-100 years. N Engl J Med 355:1412-1414
93. Gaborit N, Steenman M, Lamirault G, Le Meur N, Le Bouter S, Lande G, Leger J, Charpentier F, Christ T, Dobrev D, Escande D, Nattel S, Demolombe S (2005) Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation 112:471-481 (Pubitemid 41060786)
94. Gaspo R, Bosch RF, Bou-Abboud E, Nattel S (1997) Tachycardia-induced changes in Na + current in a chronic dog model of atrial fibrillation. Circ Res 81:1045-1052 (Pubitemid 27514955)
95. Gauldie J, Hanson JM, Rumjanek FD, Shipolini RA, Vernon CA (1976) The peptide components of bee venom. Eur J Biochem 61:369-376
96. Gautier P, Guillemare E, Djandjighian L, Marion A, Planchenault J, Bernhart C, Herbert JM, Nisato D (2004) In vivo and in vitro characterization of the novel antiarrhythmic agent SSR149744C: electrophysiological, anti-adrenergic, and anti-angiotensin II effects. J Cardiovasc Pharmacol 44:244-257 (Pubitemid 38982169)
97. Gautier P, Serre M, Cosnier-Pucheu S, Djandjighian L, Roccon A, Herbert JM, Nisato D (2005) In vivo and in vitro antiarrhythmic effects of SSR149744C in animal models of atrial fibrillation and ventricular arrhythmias. J Cardiovasc Pharmacol 45:125-135 (Pubitemid 40170675)
98. Gentles RG, Grant-Young K, Hu S, Huang Y, Poss MA, Andres C, Fiedler T, Knox R, Lodge N, Weaver CD, Harden DG (2008) Initial SAR studies on apamin-displacing 2-aminothiazole blockers of calcium-activated small conductance potassium channels. Bioorg Med Chem Lett 18:5316-5319
99. Gogelein H, Brendel J, Steinmeyer K, Strubing C, Picard N, Rampe D, Kopp K, Busch AE, Bleich M (2004) Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels. Naunyn Schmiedebergs Arch Pharmacol 370:183-192 (Pubitemid 39361854)
100. Grunnet M, Jespersen T, Rasmussen HB, Ljungstrom T, Jorgensen NK, Olesen SP, Klaerke DA (2002) KCNE4 is an inhibitory subunit to the KCNQ1 channel. J Physiol 542:119-130 (Pubitemid 35203234)
101. Grunnet M, Olesen SP, Klaerke DA, Jespersen T (2005) hKCNE4 inhibits the hKCNQ1 potassium current without affecting the activation kinetics. Biochem Biophys Res Commun 328: 1146-1153 (Pubitemid 40238754)
102. Grunnet M, Strøbæk D, Olesen SP, Christophersen P (2009) KCa1-KCa5 families. In: Kew J, Davies C (eds) Ion channels: from structure to function. Oxford University Press, Oxford, pp 403-424
103. Guillemare E, Marion A, Nisato D, Gautier P (2000) Inhibitory effects of dronedarone on muscarinic K+ current in guinea pig atrial cells. J Cardiovasc Pharmacol 36:802-805
104. Guo D, Lu Z (2000) Mechanism of IRK1 channel block by intracellular polyamines. J Gen Physiol 115:799-814
105. Guo W, Xu H, London B, Nerbonne JM (1999) Molecular basis of transient outward K + current diversity in mouse ventricular myocytes. J Physiol 521(Pt 3):587-599 (Pubitemid 30042774)
106. Guo W, Li H, Aimond F, Johns DC, Rhodes KJ, Trimmer JS, Nerbonne JM (2002) Role of heteromultimers in the generation of myocardial transient outward K+ currents. Circ Res 90: 586-593 (Pubitemid 34640909)
107. Gurney A, Manoury B (2009) Two-pore potassium channels in the cardiovascular system. Eur Biophys J 38:305-318
108. Han TS, Williams GR, Vanderpump MP (2009) Benzofuran derivatives and the thyroid. Clin Endocrinol (Oxf) 70:2-13
109. Hara M, Shvilkin A, Rosen MR, Danilo P Jr, Boyden PA (1999) Steady-state and nonsteady-state action potentials in fibrillating canine atrium: abnormal rate adaptation and its possible mechanisms. Cardiovasc Res 42:455-469 (Pubitemid 29243171)
110. Hashimoto N, Yamashita T, Tsuruzoe N (2008) Characterization of in vivo and in vitro electro-physiological and antiarrhythmic effects of a novel IKACh blocker, NIP-151: a comparison with an IKr-blocker dofetilide. J Cardiovasc Pharmacol 51:162-169 (Pubitemid 351301477)
111. Hasumi H, Matsuda R, Shimamoto K, Hata Y, Kaneko N (2007) K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization. Eur J Pharmacol 555:54-60 (Pubitemid 46013854)
112. Heginbotham L, Lu Z, Abramson T, MacKinnon R (1994) Mutations in the K+ channel signature sequence. Biophys J 66:1061-1067
113. Henry WL, Morganroth J, Pearlman AS, Clark CE, Redwood DR, Itscoitz SB, Epstein SE (1976) Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 53:273-279
114. Hille B (1992) G protein-coupled mechanisms and nervous signaling. Neuron 9:187-195
115. Hohnloser SH, Kuck KH, Lilienthal J (2000) Rhythm or rate control in atrial fibrillation-Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 356:1789-1794
116. Hohnloser SH, Dorian P, Straub M, Beckmann K, Kowey P (2004) Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter. J Am Coll Cardiol 44:99-104 (Pubitemid 38968466)
117. Hohnloser SH, Crijns HJ, van Eickels M, Gaudin C, Page RL, Torp-Pedersen C, Connolly SJ (2009) Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 360:668-678
118. Homma N, Amran MS, Nagasawa Y, Hashimoto K (2006) Topics on the Na +Ca2 + exchanger: involvement of Na +Ca2 + exchange system in cardiac triggered activity. J Pharmacol Sci 102:17-21 (Pubitemid 44440961)
119. Hondeghem LM, Snyders DJ (1990) Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. Circulation 81:686-690 (Pubitemid 20055978)
120. Hondeghem LM, Carlsson L, Duker G (2001) Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic. Circulation 103:2004-2013 (Pubitemid 32322230)
121. Inoue M, Imanaga I (1993) Masking of A-type K+ channel in guinea pig cardiac cells by extracellular Ca2+. Am J Physiol 264:C1434-C1438 (Pubitemid 23198510)
122. Isomoto S, Kurachi Y (1997) Function, regulation, pharmacology, and molecular structure of ATP-sensitive K+ channels in the cardiovascular system. J Cardiovasc Electrophysiol 8:1431-1446 (Pubitemid 28013656)
123. Jafari-Fesharaki M, Scheinman MM (1998) Adverse effects of amiodarone. Pacing Clin Electro-physiol 21:108-120
124. Jager H, Adelman JP, Grissmer S (2000) SK2 encodes the apamin-sensitive Ca(2 +)-activated K( +) channels in the human leukemic T cell line, Jurkat. FEBS Lett 469:196-202 (Pubitemid 30129220)
125. Jenkins DP, Strobaek D, Hougaard C, Jensen ML, Hummel R, Sorensen US, Christophersen P, Wulff H (2011) Negative gating modulation by (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine (NS8593) depends on residues in the inner pore vestibule: pharmacological evidence of deep-pore gating of K(Ca)2 channels. Mol Pharmacol 79:899-909
126. Jespersen T, Grunnet M, Olesen SP (2005) The KCNQ1 potassium channel: from gene to physiological function. Physiology (Bethesda) 20:408-416 (Pubitemid 41812424)
127. Juhasz A, Bodor N (2000) Cardiovascular studies on different classes of soft drugs. Pharmazie 55:228-238 (Pubitemid 30208221)
128. Kaneko N, Matsuda R, Hata Y, Shimamoto K (2009) Pharmacological characteristics and clinical applications of K201. Curr Clin Pharmacol 4:126-131
129. Kannel WB, Abbott RD, Savage DD, McNamara PM (1983) Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J 106:389-396 (Pubitemid 13028244)
130. Kaufman ES, Zimmermann PA, Wang T, Dennish GW 3rd, Barrell PD, Chandler ML, Greene HL (2004) Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis. J Am Coll Cardiol 44:1276-1282 (Pubitemid 39208885)
131. Kelly A, Elliott EB, Matsuda R, Kaneko N, Smith GL, Loughrey CM (2011) The effect of K201 on isolated working rabbit heart mechanical function during pharmacologically-induced Ca(2+) overload. Br J Pharmacol, DOI: 10.1111/j.1476-5381.2011.01531.x
132. Kneller J, Zou R, Vigmond EJ, Wang Z, Leon LJ, Nattel S (2002) Cholinergic atrial fibrillation in a computer model of a two-dimensional sheet of canine atrial cells with realistic ionic properties. Circ Res 90:E73-E87
133. Kneller J, Kalifa J, Zou R, Zaitsev AV, Warren M, Berenfeld O, Vigmond EJ, Leon LJ, Nattel S, Jalife J (2005) Mechanisms of atrial fibrillation termination by pure sodium channel blockade in an ionically-realistic mathematical model. Circ Res 96:e35-e47
134. Knobloch K, Brendel J, Peukert S, Rosenstein B, Busch AE, Wirth KJ (2002) Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide. Naunyn Schmiedebergs Arch Pharmacol 366:482-487 (Pubitemid 35244913)
135. Kodama I, Kamiya K, Toyama J (1997) Cellular electropharmacology of amiodarone. Cardiovasc Res 35:13-29 (Pubitemid 27374736)
136. Kong W, Po S, Yamagishi T, Ashen MD, Stetten G, Tomaselli GF (1998) Isolation and characterization of the human gene encoding Ito: further diversity by alternative mRNA splicing. Am J Physiol 275:H1963-H1970
137. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J (2002) Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 54:361-379 (Pubitemid 34327915)
138. Kovoor P, Wickman K, Maguire CT, Pu W, Gehrmann J, Berul CI, Clapham DE (2001) Evaluation of the role of I(KACh) in atrial fibrillation using a mouse knockout model. J Am Coll Cardiol 37:2136-2143 (Pubitemid 32548010)
139. Kowey PR, Dorian P, Mitchell LB, Pratt CM, Roy D, Schwartz PJ, Sadowski J, Sobczyk D, Bochenek A, Toft E (2009) Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial. Circ Arrhythm Electrophysiol 2:652-659
140. Kubo Y, Baldwin TJ, Jan YN, Jan LY (1993) Primary structure and functional expression of a mouse inward rectifier potassium channel. Nature 362:127-133 (Pubitemid 23085250)
141. Kumar K, Nearing BD, Carvas M, Nascimento BC, Acar M, Belardinelli L, Verrier RL (2009) Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart. J Cardiovasc Electrophysiol 20:796-802
142. Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Mahe I, Bergmann JF (2006) Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials. Arch Intern Med 166:719-728
143. Lagrutta A, Wang J, Fermini B, Salata JJ (2006) Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current. J Pharmacol Exp Ther 317:1054-1063 (Pubitemid 43764108)
144. Larsen AP, Olesen SP, Grunnet M, Jespersen T (2008) Characterization of hERG1a and hERG1b potassium channels-a possible role for hERG1b in the I (Kr) current. Pflugers Arch 456: 1137-1148
145. Le Heuzey JY, De Ferrari GM, Radzik D, Santini M, Zhu J, Davy JM (2010) A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study. J Cardiovasc Electrophysiol 21:597-605
146. Lee KS (1992) Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+ current in guinea pig ventricular cells. J Pharmacol Exp Ther 262:99-108
147. Lee DS, Goodman S, Dean DM, Lenis J, Ma P, Gervais PB, Langer A (2002) Randomized comparison of T-type versus L-type calcium-channel blockade on exercise duration in stable angina: results of the Posicor Reduction of Ischemia During Exercise (PRIDE) trial. Am Heart J 144:60-67 (Pubitemid 34734756)
148. Li D, Fareh S, Leung TK, Nattel S (1999) Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 100:87-95 (Pubitemid 29297945)
149. Li D, Melnyk P, Feng J, Wang Z, Petrecca K, Shrier A, Nattel S (2000) Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation 101:2631-2638 (Pubitemid 30350643)
150. Li GR, Lau CP, Shrier A (2002) Heterogeneity of sodium current in atrial vs epicardial ventricular myocytes of adult guinea pig hearts. J Mol Cell Cardiol 34:1185-1194 (Pubitemid 35205164)
151. Li N, Timofeyev V, Tuteja D, Xu D, Lu L, Zhang Q, Zhang Z, Singapuri A, Albert TR, Rajagopal AV, Bond CT, Periasamy M, Adelman J, Chiamvimonvat N (2009) Ablation of a Ca2+-activated K+ channel (SK2 channel) results in action potential prolongation in atrial myocytes and atrial fibrillation. J Physiol 587:1087-1100
152. Li ML, Li T, Lei M, Tan XQ, Yang Y, Liu TP, Pei J, Zeng XR (2011) [Increased small conductance calcium-activated potassium channel (SK2 channel) current in atrial myocytes of patients with persistent atrial fibrillation]. Zhonghua Xin Xue Guan Bing Za Zhi 39:147-151
153. Liegeois JF, Mercier F, Graulich A, Graulich-Lorge F, Scuvee-Moreau J, Seutin V (2003) Modulation of small conductance calcium-activated potassium (SK) channels: a new challenge in medicinal chemistry. Curr Med Chem 10:625-647 (Pubitemid 36348085)
154. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D'Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ (2004) Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 110:1042-1046 (Pubitemid 39319000)
155. London B, Trudeau MC, Newton KP, Beyer AK, Copeland NG, Gilbert DJ, Jenkins NA, Satler CA, Robertson GA (1997) Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current. Circ Res 81:870-878 (Pubitemid 27467223)
156. Lopatin AN, Nichols CG (2001) Inward rectifiers in the heart: an update on I(K1). J Mol Cell Cardiol 33:625-638 (Pubitemid 32538976)
157. Loughrey CM, Otani N, Seidler T, Craig MA, Matsuda R, Kaneko N, Smith GL (2007) K201 modulates excitation-contraction coupling and spontaneous Ca2+ release in normal adult rabbit ventricular cardiomyocytes. Cardiovasc Res 76:236-246 (Pubitemid 350198587)
158. Lu L, Zhang Q, Timofeyev V, Zhang Z, Young JN, Shin HS, Knowlton AA, Chiamvimonvat N (2007) Molecular coupling of a Ca2+-activated K+ channel to L-type Ca2+ channels via alpha-actinin2. Circ Res 100:112-120 (Pubitemid 46066779)
159. Machida T, Hashimoto N, Kuwahara I, Ogino Y, Matsuura J, Yamamoto W, Itano Y, Zamma A, Matsumoto R, Kamon J, Kobayashi T, Ishiwata N, Yamashita T, Ogura T, Nakaya H (2011) Effects of a highly selective acetylcholine-activated K+ channel blocker on experimental atrial fibrillation. Circ Arrhythm Electrophysiol 4:94-102
160. Manning A, Thisse V, Hodeige D, Richard J, Heyndrickx JP, Chatelain P (1995) SR 33589, a new amiodarone-like antiarrhythmic agent: electrophysiological effects in anesthetized dogs. J Cardiovasc Pharmacol 25:252-261
161. Marban E, O'Rourke B (1995) Calcium channels: structure, function, and regulation, in cardiac electrophysiology: from cell to bedside. WB Saunders Comp, Philadelphia
162. Marrouche NF, Reddy RK, Wittkowsky AK, Bardy GH (2000) High-dose bolus lidocaine for chemical cardioversion of atrial fibrillation: a prospective, randomized, double-blind crossover trial. Am Heart J 139:E8-E11
163. Mason JW (1987) Amiodarone. N Engl J Med 316:455-466 (Pubitemid 17035573)
164. McAllister RE, Noble D (1966) The time and voltage dependence of the slow outward current in cardiac Purkinje fibres. J Physiol 186:632-662
165. McCrossan ZA, Abbott GW (2004) The MinK-related peptides. Neuropharmacology 47:787-821 (Pubitemid 39440975)
166. McDonald TV, Yu Z, Ming Z, Palma E, Meyers MB, Wang KW, Goldstein SA, Fishman GI (1997) A minK-HERG complex regulates the cardiac potassium current I(Kr). Nature 388:289-292 (Pubitemid 27317974)
167. Medina I, Krapivinsky G, Arnold S, Kovoor P, Krapivinsky L, Clapham DE (2000) A switch mechanism for G beta gamma activation of I(KACh). J Biol Chem 275:29709-29716 (Pubitemid 32043852)
168. Moe GK, Rheinboldt WC, Abildskov JA (1964) A Computer Model of Atrial Fibrillation. Am Heart J 67:200-220
169. Morey TE, Seubert CN, Raatikainen MJ, Martynyuk AE, Druzgala P, Milner P, Gonzalez MD, Dennis DM (2001) Structure-activity relationships and electrophysiological effects of short-acting amiodarone homologs in guinea pig isolated heart. J Pharmacol Exp Ther 297:260-266 (Pubitemid 32242586)
170. Mori K, Hara Y, Saito T, Masuda Y, Nakaya H (1995) Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells. Different molecular mechanisms. Circulation 91:2834-2843
171. Munk AA, Adjemian RA, Zhao J, Ogbaghebriel A, Shrier A (1996) Electrophysiological properties of morphologically distinct cells isolated from the rabbit atrioventricular node. J Physiol 493(Pt 3):801-818 (Pubitemid 26232115)
172. Murdock DK, Kersten M, Kaliebe J, Larrain G (2009) The use of oral ranolazine to convert new or paroxysmal atrial fibrillation: a review of experience with implications for possible "pill in the pocket" approach to atrial fibrillation. Indian Pacing Electrophysiol J 9:260-267
173. Nagy ZA, Virag L, Toth A, Biliczki P, Acsai K, Banyasz T, Nanasi P, Papp JG, Varro A (2004) Selective inhibition of sodium-calcium exchanger by SEA-0400 decreases early and delayed after depolarization in canine heart. Br J Pharmacol 143:827-831 (Pubitemid 39664841)
174. Nagy N, Szuts V, Horvath Z, Seprenyi G, Farkas AS, Acsai K, Prorok J, Bitay M, Kun A, Pataricza J, Papp JG, Nanasi PP, Varro A, Toth A (2009) Does small-conductance calcium-activated potassium channel contribute to cardiac repolarization? J Mol Cell Cardiol 47:656-663
175. Namekata I, Tsuruoka N, Tsuneoka Y, Matsuda T, Takahara A, Tanaka Y, Suzuki T, Takahashi T, Iida-Tanaka N, Tanaka H (2011) Blocking effect of NIP-142 on the KCNQ1/KCNE1 channel current expressed in HEK293 cells. Biol Pharm Bull 34:153-155
176. Nattel S (2002) New ideas about atrial fibrillation 50 years on. Nature 415:219-226 (Pubitemid 34059528)
177. Nattel S (2009) Calcium-activated potassium current: a novel ion channel candidate in atrial fibrillation. J Physiol 587:1385-1386
178. Nattel S, Carlsson L (2006) Innovative approaches to anti-arrhythmic drug therapy. Nat Rev Drug Discov 5:1034-1049 (Pubitemid 44835130)
179. Nattel S, Shiroshita-Takeshita A, Brundel BJ, Rivard L (2005) Mechanisms of atrial fibrillation: lessons from animal models. Prog Cardiovasc Dis 48:9-28 (Pubitemid 41368555)
180. Nattel S, Maguy A, Le Bouter S, Yeh YH (2007) Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 87:425-456 (Pubitemid 47084677)
181. Nattel S, Burstein B, Dobrev D (2008) Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol 1:62-73
182. Nerbonne JM (2000) Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium. J Physiol 525(Pt 2):285-298 (Pubitemid 30398360)
183. Nerbonne JM, Kass RS (2005) Molecular physiology of cardiac repolarization. Physiol Rev 85: 1205-1253 (Pubitemid 41362269)
184. Nilius B, Hess P, Lansman JB, Tsien RW (1985) A novel type of cardiac calcium channel in ventricular cells. Nature 316:443-446 (Pubitemid 16238453)
185. Okishige K, Nishizaki M, Azegami K, Igawa M, Yamawaki N, Aonuma K (2000) Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study. Am Heart J 140:e13
186. Olson TM, Alekseev AE, Liu XK, Park S, Zingman LV, Bienengraeber M, Sattiraju S, Ballew JD, Jahangir A, Terzic A (2006) Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. Hum Mol Genet 15:2185-2191 (Pubitemid 43985509)
187. Opolski G, Torbicki A, Kosior DA, Szulc M, Wozakowska-Kaplon B, Kolodziej P, Achremczyk P (2004) Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. Chest 126:476-486 (Pubitemid 39093433)
188. Orth PM, Hesketh JC, Mak CK, Yang Y, Lin S, Beatch GN, Ezrin AM, Fedida D (2006) RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents. Cardiovasc Res 70:486-496
189. Ozgen N, Dun W, Sosunov EA, Anyukhovsky EP, Hirose M, Duffy HS, Boyden PA, Rosen MR (2007) Early electrical remodeling in rabbit pulmonary vein results from trafficking of intra-cellular SK2 channels to membrane sites. Cardiovasc Res 75:758-769 (Pubitemid 47238736)
190. Pandit SV, Berenfeld O, Anumonwo JM, Zaritski RM, Kneller J, Nattel S, Jalife J (2005) Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. Biophys J 88:3806-3821 (Pubitemid 40991096)
191. Patel C, Yan GX, Kowey PR (2009) Dronedarone. Circulation 120:636-644
192. Pedersen OD, Bagger H, Keller N, Marchant B, Kober L, Torp-Pedersen C (2001) Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy. Circulation 104:292-296 (Pubitemid 32666950)
193. Perez-Reyes E (2003) Molecular physiology of low-voltage-activated t-type calcium channels. Physiol Rev 83:117-161 (Pubitemid 36459879)
194. Pertsov AM, Davidenko JM, Salomonsz R, Baxter WT, Jalife J (1993) Spiral waves of excitation underlie reentrant activity in isolated cardiac muscle. Circ Res 72:631-650 (Pubitemid 23052161)
195. Piccini JP, Hasselblad V, Peterson ED, Washam JB, Califf RM, Kong DF (2009) Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. J Am Coll Cardiol 54:1089-1095
196. Pinto JM, Boyden PA (1998) Reduced inward rectifying and increased E-4031-sensitive K+ current density in arrhythmogenic subendocardial purkinje myocytes from the infarcted heart. J Cardiovasc Electrophysiol 9:299-311 (Pubitemid 28180467)
197. Piper DR, Hinz WA, Tallurri CK, Sanguinetti MC, Tristani-Firouzi M (2005) Regional specificity of human ether-a'-go-go-related gene channel activation and inactivation gating. J Biol Chem 280:7206-7217 (Pubitemid 40341278)
198. Polontchouk L, Haefliger JA, Ebelt B, Schaefer T, Stuhlmann D, Mehlhorn U, Kuhn-Regnier F, De Vivie ER, Dhein S (2001) Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 38:883-891 (Pubitemid 32835768)
199. Pratt CM, Camm AJ, Cooper W, Friedman PL, MacNeil DJ, Moulton KM, Pitt B, Schwartz PJ, Veltri EP, Waldo AL (1998) Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die? Am J Cardiol 81:869-876 (Pubitemid 28204641)
200. Pratt CM, Roy D, Torp-Pedersen C, Wyse DG, Toft E, Juul-Moller S, Retyk E, Drenning DH (2010) Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation. Am J Cardiol 106:1277-1283
201. Pribnow D, Johnson-Pais T, Bond CT, Keen J, Johnson RA, Janowsky A, Silvia C, Thayer M, Maylie J, Adelman JP (1999) Skeletal muscle and small-conductance calcium-activated potassium channels. Muscle Nerve 22:742-750 (Pubitemid 29256843)
202. Radicke S, Cotella D, Graf EM, Ravens U, Wettwer E (2005) Expression and function of dipeptidyl-aminopeptidase-like protein 6 as a putative beta-subunit of human cardiac transient outward current encoded by Kv4.3. J Physiol 565:751-756 (Pubitemid 40903290)
203. Ravens U, Dobrev D (2003) Cardiac sympathetic innervation and control of potassium channel function. J Mol Cell Cardiol 35:137-139 (Pubitemid 36269187)
204. Regan CP, Wallace AA, Cresswell HK, Atkins CL, Lynch JJ Jr (2006) In vivo cardiac electro-physiologic effects of a novel diphenylphosphine oxide IKur blocker, (2-Isopropyl-5-methylcyclohexyl) diphenylphosphine oxide, in rat and nonhuman primate. J Pharmacol Exp Ther 316:727-732 (Pubitemid 43131000)
205. Roden DM (1998) Taking the "idio" out of " idiosyncratic": predicting torsades de pointes. Pacing Clin Electrophysiol 21:1029-1034
206. Rogart RB, Cribbs LL, Muglia LK, Kephart DD, Kaiser MW (1989) Molecular cloning of a putative tetrodotoxin-resistant rat heart Na+ channel isoform. Proc Natl Acad Sci USA 86: 8170-8174 (Pubitemid 19265340)
207. Romey G, Hugues M, Schmid-Antomarchi H, Lazdunski M (1984) Apamin: a specific toxin to study a class of Ca2+-dependent K+ channels. J Physiol (Paris) 79:259-264 (Pubitemid 15197136)
208. Ronaszeki A, Alings M, Egstrup K, Gaciong Z, Hranai M, Kiraly C, Sereg M, Figatowski W, Bondarov P, Johansson S, Frison L, Edvardsson N, Berggren A (2011) Pharmacological cardioversion of atrial fibrillation-a double-blind, randomized, placebo-controlled, multi-centre, dose-escalation study of AZD1305 given intravenously. Europace 13:1148-1156
209. Rosa JC, Galanakis D, Ganellin CR, Dunn PM, Jenkinson DH (1998) Bis-quinolinium cyclophanes: 6,10-diaza-3(1,3),8(1,4)-dibenzena-1,5(1,4)- diquinolinacyclodecaphane (UCL 1684), the first nanomolar, non-peptidic blocker of the apamin-sensitive Ca(2+)-activated K+ channel. J Med Chem 41:2-5 (Pubitemid 128719272)
210. Rosati B, Pan Z, Lypen S, Wang HS, Cohen I, Dixon JE, McKinnon D (2001) Regulation of KChIP2 potassium channel beta subunit gene expression underlies the gradient of transient outward current in canine and human ventricle. J Physiol 533:119-125 (Pubitemid 32499364)
211. Roy D, Rowe BH, Stiell IG, Coutu B, Ip JH, Phaneuf D, Lee J, Vidaillet H, Dickinson G, Grant S, Ezrin AM, Beatch GN (2004) A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation. J Am Coll Cardiol 44: 2355-2361 (Pubitemid 39647610)
212. Roy D, Pratt CM, Torp-Pedersen C, Wyse DG, Toft E, Juul-Moller S, Nielsen T, Rasmussen SL, Stiell IG, Coutu B, Ip JH, Pritchett EL, Camm AJ (2008) Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial. Circulation 117:1518-1525 (Pubitemid 351440640)
213. Sanders P, Morton JB, Kistler PM, Vohra JK, Kalman JM, Sparks PB (2003) Reversal of atrial mechanical dysfunction after cardioversion of atrial fibrillation: implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy. Circulation 108:1976-1984 (Pubitemid 37296542)
214. Sanguinetti MC, Tristani-Firouzi M (2006) hERG potassium channels and cardiac arrhythmia. Nature 440:463-469
215. Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL, Keating MT (1996) Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 384:80-83 (Pubitemid 26374592)
216. Satoh T, Zipes DP (1998) Cesium-induced atrial tachycardia degenerating into atrial fibrillation in dogs: atrial torsades de pointes? J Cardiovasc Electrophysiol 9:970-975 (Pubitemid 28455966)
217. Schotten U, de Haan S, Verheule S, Harks EG, Frechen D, Bodewig E, Greiser M, Ram R, Maessen J, Kelm M, Allessie M, Van Wagoner DR (2007) Blockade of atrial-specific K+-currents increases atrial but not ventricular contractility by enhancing reverse mode Na +Ca2+-exchange. Cardiovasc Res 73:37-47 (Pubitemid 44937207)
218. Schram G, Pourrier M, Melnyk P, Nattel S (2002) Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function. Circ Res 90:939-950 (Pubitemid 34633859)
219. Scirica BM, Morrow DA, Hod H, Murphy SA, Belardinelli L, Hedgepeth CM, Molhoek P, Verheugt FW, Gersh BJ, McCabe CH, Braunwald E (2007) Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation 116:1647-1652 (Pubitemid 47537839)
220. Shi Y, Ducharme A, Li D, Gaspo R, Nattel S, Tardif JC (2001) Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation. Cardiovasc Res 52:217-225 (Pubitemid 33000398)
221. Shinagawa K, Shi YF, Tardif JC, Leung TK, Nattel S (2002) Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs. Circulation 105:2672-2678 (Pubitemid 34596046)
222. Shorofsky SR, January CT (1992) L-and T-type Ca2+ channels in canine cardiac Purkinje cells. Single-channel demonstration of L-type Ca2+ window current. Circ Res 70:456-464
223. Sicouri S, Burashnikov A, Belardinelli L, Antzelevitch C (2010) Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria. Circ Arrhythm Electrophysiol 3:88-95
224. Sills MN, Xu YC, Baracchini E, Goodman RH, Cooperman SS, Mandel G, Chien KR (1989) Expression of diverse Na+ channel messenger RNAs in rat myocardium. Evidence for a cardiac-specific Na+ channel. J Clin Invest 84:331-336 (Pubitemid 19170126)
225. Singh BN, Connolly SJ, Crijns HJ, Roy D, Kowey PR, Capucci A, Radzik D, Aliot EM, Hohnloser SH (2007) Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med 357:987-999 (Pubitemid 47367078)
226. Skanes AC, Gray RA, Zuur CL, Jalife J (1998) Effects of postshock atrial pacing on atrial defibrillation outcome in the isolated sheep heart. Circulation 98:64-72 (Pubitemid 28312081)
227. Skibsbye L, Diness JG, Sorensen US, Hansen RS, Grunnet M (2011) The Duration of Pacing-induced Atrial Fibrillation Is Reduced in Vivo by Inhibition of Small Conductance Ca2+-activated K+ Channels. J Cardiovasc Pharmacol 57:672-681
228. Soldatov NM (1994) Genomic structure of human L-type Ca2+ channel. Genomics 22:77-87 (Pubitemid 24234090)
229. Soltysinska E, Olesen SP, Christ T, Wettwer E, Varro A, Grunnet M, Jespersen T (2009) Transmural expression of ion channels and transporters in human nondiseased and end-stage failing hearts. Pflugers Arch 459:11-23
230. Sorensen US, Strobaek D, Christophersen P, Hougaard C, Jensen ML, Nielsen EO, Peters D, Teuber L (2008) Synthesis and structure-activity relationship studies of 2-(N-substituted)-aminobenzimidazoles as potent negative gating modulators ofsmall conductance Ca2+-activated K+ channels. J Med Chem 51:7625-7634
231. Sossalla S, Kallmeyer B, Wagner S, Mazur M, Maurer U, Toischer K, Schmitto JD, Seipelt R, Schondube FA, Hasenfuss G, Belardinelli L, Maier LS (2010) Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium. J Am Coll Cardiol 55:2330-2342
232. Splawski I, Tristani-Firouzi M, Lehmann MH, Sanguinetti MC, Keating MT (1997) Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet 17:338-340 (Pubitemid 27476001)
233. Sridhar A, da Cunha DN, Lacombe VA, Zhou Q, Fox JJ, Hamlin RL, Carnes CA (2007) The plateau outward current in canine ventricle, sensitive to 4-aminopyridine, is a constitutive contributor to ventricular repolarization. Br J Pharmacol 152:870-879 (Pubitemid 350100487)
234. Stocker M (2004) Ca(2+)-activated K+ channels: molecular determinants and function of the SK family. Nat Rev Neurosci 5:758-770 (Pubitemid 39336213)
235. Strobaek D, Hougaard C, Johansen TH, Sorensen US, Nielsen EO, Nielsen KS, Taylor RD, Pedarzani P, Christophersen P (2006) Inhibitory gating modulation of small conductance Ca2+-activated K+ channels by the synthetic compound (R)-N-(benzimidazol-2-yl)-1,2,3, 4-tetrahydro-1-naphtylamine (NS8593) reduces afterhyperpolarizing current in hippocampal CA1 neurons. Mol Pharmacol 70:1771-1782
236. Strutz-Seebohm N, Gutcher I, Decher N, Steinmeyer K, Lang F, Seebohm G (2007) Comparison of potent Kv1.5 potassium channel inhibitors reveals the molecular basis for blocking kinetics and binding mode. Cell Physiol Biochem 20:791-800 (Pubitemid 350059722)
237. Sun W, Sarma JS, Singh BN (1999) Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart: comparison with amiodarone. Circulation 100:2276-2281
238. Sun W, Sarma JS, Singh BN (2002) Chronic and acute effects of dronedarone on the action potential of rabbit atrial muscle preparations: comparison with amiodarone. J Cardiovasc Pharmacol 39:677-684 (Pubitemid 34453953)
239. Takahashi N, Morishige K, Jahangir A, Yamada M, Findlay I, Koyama H, Kurachi Y (1994) Molecular cloning and functional expression of cDNA encoding a second class of inward rectifier potassium channels in the mouse brain. J Biol Chem 269:23274-23279 (Pubitemid 24283317)
240. Tamargo J, Caballero R, Gomez R, Valenzuela C, Delpon E (2004) Pharmacology of cardiac potassium channels. Cardiovasc Res 62:9-33 (Pubitemid 38326808)
241. Tanaka H, Hashimoto N (2007) A multiple ion channel blocker, NIP-142, for the treatment of atrial fibrillation. Cardiovasc Drug Rev 25:342-356 (Pubitemid 350237625)
242. Tanaka H, Namekata I, Hamaguchi S, Kawamura T, Masuda H, Tanaka Y, Iida-Tanaka N, Takahara A (2010) Effect of NIP-142 on potassium channel alpha-subunits Kv1.5, Kv4.2 and Kv4.3, and mouse atrial repolarization. Biol Pharm Bull 33:138-141
243. Toivonen L, Raatikainen P, Walfridsson H, Englund A, Hegbom F, Anfinsen OG, Gjesdal K, Pehrson S, Johansson S, Frison L, Berggren AR, Edvardsson N (2010) A randomized invasive cardiac electrophysiology study of the combined ion channel blocker AZD1305 in patients after catheter ablation of atrial flutter. J Cardiovasc Pharmacol 56:300-308
244. Topert C, Doring F, Wischmeyer E, Karschin C, Brockhaus J, Ballanyi K, Derst C, Karschin A (1998) Kir2.4: a novel K+ inward rectifier channel associated with motoneurons of cranial nerve nuclei. J Neurosci 18:4096-4105 (Pubitemid 28243806)
245. Touboul P, Brugada J, Capucci A, Crijns HJ, Edvardsson N, Hohnloser SH (2003) Dronedarone for prevention of atrial fibrillation: a dose-ranging study. Eur Heart J 24:1481-1487 (Pubitemid 37010577)
246. Tuteja D, Xu D, Timofeyev V, Lu L, Sharma D, Zhang Z, Xu Y, Nie L, Vazquez AE, Young JN, Glatter KA, Chiamvimonvat N (2005) Differential expression of small-conductance Ca2+-activated K+ channels SK1, SK2, and SK3 in mouse atrial and ventricular myocytes. Am J Physiol Heart Circ Physiol 289:H2714-H2723 (Pubitemid 41698589)
247. Tuteja D, Rafizadeh S, Timofeyev V, Wang S, Zhang Z, Li N, Mateo RK, Singapuri A, Young JN, Knowlton AA, Chiamvimonvat N (2010) Cardiac small conductance Ca2+-activated K+ channel subunits form heteromultimers via the coiled-coil domains in the C termini of the channels. Circ Res 107:851-859
248. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834-1840 (Pubitemid 35417774)
249. Van Wagoner DR, Pond AL, McCarthy PM, Trimmer JS, Nerbonne JM (1997) Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 80:772-781 (Pubitemid 27230051)
250. Vandenberg CA (1987) Inward rectification of a potassium channel in cardiac ventricular cells depends on internal magnesium ions. Proc Natl Acad Sci USA 84:2560-2564 (Pubitemid 17075906)
251. Venetucci LA, Trafford AW, O'Neill SC, Eisner DA (2007) Na/Ca exchange: regulator of intracellular calcium and source of arrhythmias in the heart. Ann N Y Acad Sci 1099:315-325 (Pubitemid 47092597)
252. Vergara C, Latorre R, Marrion NV, Adelman JP (1998) Calcium-activated potassium channels. Curr Opin Neurobiol 8:321-329 (Pubitemid 28288566)
253. Vick JA, Hassett CC, Shipman WH (1972) Beta Adrenergic and Antiarrhythmic Effect of Apamin, A Component of Bee Venom. Edgewood Arsenal Technical Report EATR 4664:1-13
254. Voigt N, Maguy A, Yeh YH, Qi X, Ravens U, Dobrev D, Nattel S (2008) Changes in I K, ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes. Cardiovasc Res 77:35-43 (Pubitemid 351195163)
255. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 348:7-12 (Pubitemid 26237238)
256. Wang DW, Yazawa K, George AL Jr, Bennett PB (1996) Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome. Proc Natl Acad Sci USA 93: 13200-13205 (Pubitemid 26382793)
257. Wang W, Watanabe M, Nakamura T, Kudo Y, Ochi R (1999) Properties and expression of Ca2+-activated K+ channels in H9c2 cells derived from rat ventricle. Am J Physiol 276: H1559-H1566 (Pubitemid 29246542)
258. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107:2920-2925 (Pubitemid 36736633)
259. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA III, Page RL, Ezekowitz MD, Slotwiner DJ, Jackman WM, Stevenson WG, Tracy CM, Fuster V, Ryden LE, Cannom DS, Le Heuzey JY, Crijns HJ, Lowe JE, Curtis AB, Olsson SB, Ellenbogen KA, Prystowsky EN, Halperin JL, Tamargo JL, Kay GN, Wann LS, Jacobs AK, Anderson JL, Albert N, Hochman JS, Buller CE, Kushner FG, Creager MA, Ohman EM, Ettinger SM, Stevenson WG, Guyton RA, Tarkington LG, Halperin JL, Yancy CW (2011) 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 123:104-123
260. Watanabe Y, Hara Y, Tamagawa M, Nakaya H (1996) Inhibitory effect of amiodarone on the muscarinic acetylcholine receptor-operated potassium current in guinea pig atrial cells. J Pharmacol Exp Ther 279:617-624 (Pubitemid 27166832)
261. Weatherall KL, Goodchild SJ, Jane DE, Marrion NV (2010) Small conductance calcium-activated potassium channels: from structure to function. Prog Neurobiol 91:242-255
262. Weerapura M, Nattel S, Chartier D, Caballero R, Hebert TE (2002) A comparison of currents carried by HERG, with and without coexpression of MiRP1, and the native rapid delayed rectifier current. Is MiRP1 the missing link? J Physiol 540:15-27 (Pubitemid 35174983)
263. Weidmann S (1951) Effect of current flow on the membrane potential of cardiac muscle. J Physiol 115:227-236
264. Wettwer E, Hala O, Christ T, Heubach JF, Dobrev D, Knaut M, Varro A, Ravens U (2004) Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation. Circulation 110:2299-2306 (Pubitemid 39407330)
265. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA (1995) Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92:1954-1968
266. Wijffels MC, Dorland R, Mast F, Allessie MA (2000) Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. Circulation 102:260-267 (Pubitemid 30451786)
267. Wirth KJ, Paehler T, Rosenstein B, Knobloch K, Maier T, Frenzel J, Brendel J, Busch AE, Bleich M (2003) Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs. Cardiovasc Res 60:298-306 (Pubitemid 37412363)
268. Wirth KJ, Brendel J, Steinmeyer K, Linz DK, Rutten H, Gogelein H (2007) In vitro and in vivo effects of the atrial selective antiarrhythmic compound AVE1231. J Cardiovasc Pharmacol 49:197-206 (Pubitemid 46626011)
269. Wittekindt OH, Visan V, Tomita H, Imtiaz F, Gargus JJ, Lehmann-Horn F, Grissmer S, Morris-Rosendahl DJ (2004) An apamin-and scyllatoxin-insensitive isoform of the human SK3 channel. Mol Pharmacol 65:788-801 (Pubitemid 38264047)
270. Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983-988
271. Workman AJ, Kane KA, Rankin AC (2001) The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation. Cardiovasc Res 52:226-235 (Pubitemid 33000399)
272. Wulff H, Kolski-Andreaco A, Sankaranarayanan A, Sabatier JM, Shakkottai V (2007) Modulators of small-and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr Med Chem 14:1437-1457 (Pubitemid 46902225)
273. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825-1833 (Pubitemid 35417773)
274. Xia XM, Fakler B, Rivard A, Wayman G, Johnson-Pais T, Keen JE, Ishii T, Hirschberg B, Bond CT, Lutsenko S, Maylie J, Adelman JP (1998) Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature 395:503-507 (Pubitemid 28462445)
275. Xu H, Guo W, Nerbonne JM (1999) Four kinetically distinct depolarization-activated K+ currents in adult mouse ventricular myocytes. J Gen Physiol 113:661-678
276. Xu Y, Tuteja D, Zhang Z, Xu D, Zhang Y, Rodriguez J, Nie L, Tuxson HR, Young JN, Glatter KA, Vazquez AE, Yamoah EN, Chiamvimonvat N (2003) Molecular identification and functional roles of a Ca(2+)-activated K+ channel in human and mouse hearts. J Biol Chem 278: 49085-49094
277. Yagi T, Pu J, Chandra P, Hara M, Danilo P Jr, Rosen MR, Boyden PA (2002) Density and function of inward currents in right atrial cells from chronically fibrillating canine atria. Cardiovasc Res 54:405-415 (Pubitemid 34327919)
278. Yamashita T, Murakawa Y, Ajiki K, Omata M (1997) Incidence of induced atrial fibrillation/flutter in complete atrioventricular block. A concept of 'atrial-malfunctioning' atrio-hisian block. Circulation 95:650-654 (Pubitemid 27063042)
279. Yamawake N, Hirano Y, Sawanobori T, Hiraoka M (1992) Arrhythmogenic effects of isoprotere-nol-activated Cl-current in guinea-pig ventricular myocytes. J Mol Cell Cardiol 24:1047-1058
280. Yang Y, Li J, Lin X, Yang Y, Hong K, Wang L, Liu J, Li L, Yan D, Liang D, Xiao J, Jin H, Wu J, Zhang Y, Chen YH (2009) Novel KCNA5 loss-of-function mutations responsible for atrial fibrillation. J Hum Genet 54:277-283
281. Yang Y, Yang Y, Liang B, Liu J, Li J, Grunnet M, Olesen SP, Rasmussen HB, Ellinor PT, Gao L, Lin X, Li L, Wang L, Xiao J, Liu Y, Liu Y, Zhang S, Liang D, Peng L, Jespersen T, Chen YH (2010) Identification of a Kir3.4 mutation in congenital long QT syndrome. Am J Hum Genet 86:872-880
282. Yeh YH, Lemola K, Nattel S (2007) Vagal atrial fibrillation. Acta Cardiol Sin 23:1-12 (Pubitemid 46770055)
283. Yu FH, Catterall WA (2003) Overview of the voltage-gated sodium channel family. Genome Biol 4:207
284. Yu T, Wu RB, Guo HM, Deng CY, Zheng SY, Kuang SJ (2011) [Expression and functional role of small conductance Ca(2+)-activated K(+) channels in human atrial myocytes]. Nan Fang Yi Ke Da Xue Xue Bao 31:490-494
285. Yue L, Feng J, Gaspo R, Li GR, Wang Z, Nattel S (1997) Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 81:512-525 (Pubitemid 27432738)
286. Zeng J, Rudy Y (1995) Early afterdepolarizations in cardiac myocytes: mechanism and rate dependence. Biophys J 68:949-964
287. Zhang Z, Xu Y, Song H, Rodriguez J, Tuteja D, Namkung Y, Shin HS, Chiamvimonvat N (2002) Functional Roles of Ca(v)1.3 (alpha(1D)) calcium channel in sinoatrial nodes: insight gained using gene-targeted null mutant mice. Circ Res 90:981-987 (Pubitemid 34633864)
288. Zhang H, Garratt CJ, Zhu J, Holden AV (2005) Role of up-regulation of IK1 in action potential shortening associated with atrial fibrillation in humans. Cardiovasc Res 66:493-502 (Pubitemid 40725761)
289. Zhang H, Shepherd N, Creazzo TL (2008) Temperature-sensitive TREK currents contribute to setting the resting membrane potential in embryonic atrial myocytes. J Physiol 586:3645-3656
290. Zimmer T, Bollensdorff C, Haufe V, Birch-Hirschfeld E, Benndorf K (2002) Mouse heart Na+ channels: primary structure and function of two isoforms and alternatively spliced variants. Am J Physiol Heart Circ Physiol 282:H1007-H1017 (Pubitemid 34654940)
291. Zygmunt AC, Goodrow RJ, Weigel CM (1998) INaCa and ICl(Ca) contribute to isoproterenol-induced delayed after depolarizations in midmyocardial cells. Am J Physiol 275: H1979-H1992